Implantable Loop Recorder Market Size, Share and Trends Analysis - Global - 2022-2028 - MedCore

Implantable Loop Recorder Market Size, Share and Trends Analysis - Global - 2022-2028 - MedCore

The global implantable loop recorder market was valued at over $1.3 billion in 2021 and is expected to grow at a CAGR of 7.9% to reach $2.3 billion by the end of the forecast period.

Our medical market research analyzed companies in over 70 countries and applied a comprehensive methodology to determine market size, unit sales, and company market share, leading to accurate market projections.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2028, and Historical Data to 2018
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

PROCEDURE NUMBERS

The COVID-19 pandemic significantly impacted the number of ILR procedures in 2020, but it was expected to fully recover in 2021, surpassing the procedure levels of 2019. Despite the decline and recovery in 2020 and 2021 due to postponed elective procedures, the number of ILR procedures is expected to grow at a moderate to high single-digit rate during the forecast period.

GLOBAL IMPLANTABLE LOOP RECORDER MARKET TRENDS

The use of ILR devices is anticipated to rise due to aging populations. The growth rate of these devices is projected to be higher in lower-income nations as access to healthcare improves over time.

GLOBAL IMPLANTABLE LOOP RECORDER MARKET SHARE INSIGHTS

The three dominant main competitors in the Global Implantable Loop Recorder Market are: Medtronic, Abbott and Boston Scientific.

Medtronic held the top position in the implantable loop recorder market in 2021 with its product offerings such as the Reveal LINQ™ and Reveal XT™.

GLOBAL ICD MARKET SEGMENTATION SUMMARY

Implantable loop recorder market

RESEARCH SCOPE SUMMARY

Regions : North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2021
Forecast: 2022-2028
Historical Data: 2018-2021
Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE IDATA?

Experts Only– iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.